Stock Price
1,513.00
Daily Change
11.35 0.76%
Monthly
10.62%
Yearly
26.96%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR350.34B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Cipla INR 344.32B 15.13B Mar/2026
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Dr.Reddys Laboratories INR 378.92B 3.16B Mar/2026
Hindustan Unilever INR 487.39B 230M Mar/2026
Sun Pharmaceuticals INR 778.2B 56.02B Sep/2025
UPL INR 346.96B 28.02B Mar/2026